Frederick W Holtsberg

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

PLoS neglected tropical diseases

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Ujjwol Khatri, Neetu Dayal, Xueqing Hu, Elizabeth Larocque, Nimishetti Naganna, Tao Shen, Xuan Liu, Frederick W Holtsberg, M Javad Aman, Herman O Sintim, Jie Wu
Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors. Molecular cancer therapeutics (2023)
Ryan J Malonis, James T Earnest, Arthur S Kim, Matthew Angeliadis, Frederick W Holtsberg, M Javad Aman, Rohit K Jangra, Kartik Chandran, Johanna P Daily, Michael S Diamond, Margaret Kielian, Jonathan R Lai
Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses. Proceedings of the National Academy of Sciences of the United States of America 118 (37) (2021)
J Charles Whitbeck, Anu Thomas, Kathryn Kadash-Edmondson, Ariadna Grinyo-Escuer, Lewis J Stafford, Celine Cheng, Grant C Liao, Frederick W Holtsberg, M Javad Aman, Graham Simmons, Edgar Davidson, Benjamin J Doranz
Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications. PLoS neglected tropical diseases 14 (11) (2020)
Jose A Quiroz, Ryan J Malonis, Larissa B Thackray, Courtney A Cohen, Jesper Pallesen, Rohit K Jangra, Rebecca S Brown, Daniel Hofmann, Frederick W Holtsberg, Sergey Shulenin, Elisabeth K Nyakatura, Lorellin A Durnell, Vinayak Rayannavar, Johanna P Daily, Andrew B Ward, M Javad Aman, John M Dye, Kartik Chandran, Michael S. Diamond, Margaret Kielian, Jonathan R Lai
Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins. PLoS pathogens 15 (11) (2019)